27 Mar 2018 - 29 Mar 2018
Under the four main pillars of priority sectors to be developed : API, biotechnology, vaccines and natural products, the rationale includes objectives to raise the pharma industry’s competitiveness locally and globally, encouraging Pharma products diversification, driving the development of technology as well as R&D competency. As a pharmerging nation with average economic growth of 12% annually, Indonesia has a huge potential and opportunity. Strengthening the pharma industry is vital in improving social infrastructure, considering that medicine is an irreplaceable component in healthcare to promote the public health standard.
The 7th edition of CPhI South East Asia will return to the Jakarta International Expo on March 27 to 29, 2018. A dedicated platform of business networking, the event provide a good mix of pharma manufacturing supply chain from raw materials to finished dosage. Concurrently with CPhI South East Asia, a focus on functional food, nutraceuticals and nutrition is also highlighted under Health ingredients (Hi) South East Asia, all at the same time, the same place!
Two main conferences will be held to offer latest insights, regulatory and market updates in the industry : CPhI South East Asia Conference “Accelerating Growth and Development of Pharmaceutical Industry in South East Asia” (2 days on March 28 – 29) and Hi South East Asia Conference “Opportunities in Developing & Implementing Sustainable Functional Foods & Nutraceuticals” (1 day on March 28).
For more information on how you may participate or benefit from CPhI South East Asia, please visit www.cphi.com/sea or email us at cphi-sea@ubm.com for inquiries.
Read More from OBG
